Quantcast

Latest Dana-Farber Cancer Institute Stories

2011-04-28 00:15:44

Like brainy bookworms unprepared for the rough and tumble of post-graduation life, white blood cells trained by scientists to attack tumors tend to fade away quickly when injected into cancer patients. Dana-Farber Cancer Institute scientists, however, have developed a technique that can cause such cells to survive in patients' bloodstreams for well over a year, in some cases, without the need of other, highly toxic treatments, a new study shows. In a paper published in the Apr. 27 issue of...

2011-04-06 07:49:06

By: Rhonda Craig, Ivanhoe Health Correspondent A leukemia drug may be used as a new target therapy for some lung cancer patients. Nearly 150,000 Americans die of lung cancer each year, and squamous cell lung cancers account for at least 30 percent these deaths. Scientists at the Dana-Farber Cancer Institute have identified a mutation in the DDR2 gene that may indicate which squamous cell lung cancer patients will respond to the drug dasatinib. The findings were presented at the American...

2011-04-04 07:00:00

COLUMBUS, Ga., April 4, 2011 /PRNewswire/ -- Aflac, the company that helps employers enhance benefits offerings to employees, today announced it will donate a total of $1,060,000 to the American Association for Cancer Research (AACR) to help defray the costs facing cancer researchers. The three-year scholarship awards focus on career development, scholar-in-training; a special program for high school students, and a task force on pediatric oncology. The company is announcing the...

2011-04-04 08:06:28

(Ivanhoe Newswire) -- Scientists have achieved one of the oldest and most rarely achieved goals of cancer research"”they have found a way to "distract" cancer cells from their normal activities and make them act like normal cells. The scientists, from Dana-Farber Cancer Institute and Brigham and Women's Hospital, managed to distract the cancer cells of a rare form of cancer called NUT midline carcinoma (NMC) that usually affects children and young adults. NMC is lethal; according to...

2011-04-01 15:20:37

A section of the AIDS virus's protein envelope once considered an improbable target for a vaccine now appears to be one of the most promising, new research by Dana-Farber Cancer Institute scientists indicates. The section, a twisting strand of protein known as the V3 loop, is an attractive vaccine target because immune system antibodies aimed at the loop may offer protection against multiple genetic subtypes of HIV-1, the virus that causes AIDS. This is a key prerequisite of any AIDS vaccine...

2011-03-28 04:00:00

Innovative international research consortium's first study opens SAN FRANCISCO, March 28, 2011 /PRNewswire-USNewswire/ -- The Addario Lung Cancer Medical Institute (ALCMI, voiced as "Alchemy") today announced the enrollment of the initial subjects into its inaugural clinical trial known as CASTLE, targeting 250 subjects over two years among academic and community medical centers in the United States. CASTLE stands for Collaborative Advanced Stage Tissue Lung Cancer study. (Photo:...

2011-03-25 19:04:34

First drug approved in more than a decade The U.S. Food and Drug Administration today approved the use of ipilimumab for the treatment of previously treated metastatic melanoma. It is the first drug approved for metastatic, or advanced, melanoma is more than a decade. "Ipilimumab is the first in a new class of drugs that has been shown to offer a survival benefit for metastatic melanoma, which is often a fatal disease, and hopefully, this will lead to the development of related treatments for...

2011-03-24 08:30:00

BOSTON, March 24, 2011 /PRNewswire/ -- John Legere, CEO of Global Crossing, is nearing the finish line of his goal to raise $1 million for cancer research at Dana-Farber Cancer Institute. On April 18, Legere will run in the 115th Boston Marathon, his seventh as a member of the Dana-Farber Marathon Challenge team. He is the all-time leading fundraiser for the Dana-Farber Marathon Challenge and is less than $150,000 away from reaching his $1 million goal. "This is a remarkable...

07c605cfe9cf2854ff18c15b2aa8389a1
2011-03-24 05:40:00

Scientists reported on Wednesday that they have sequenced the entire genetic code of 38 multiple myeloma patients, and have uncovered the most likely genetic causes of the aggressive blood cancer. The work, carried out by 21 institutions in the U.S. and Canada, offers the most comprehensive picture to date of the full genetic blueprint of multiple myeloma, and provides new and unexpected insights into the events that lead to the disease. "For the first time, we are able to see on a molecular...

2011-03-15 20:39:13

Promising strategy moves quickly to human trials Dana-Farber Cancer Institute scientists report they have shrunk or slowed the growth of notoriously resistant pancreatic tumors in mice, using a drug routinely prescribed for malaria and rheumatoid arthritis. The pre-clinical results, which will appear in the April issue of the journal Genes & Development and is currently published on its web site, have already prompted the opening of a small clinical trial in patients with advanced...


Word of the Day
maffling
  • To stammer.
  • Present participle of maffle, to stammer.
  • A simpleton.
The word 'maffle' may come from a Dutch word meaning 'to move the jaws' or a French word meaning 'having large cheeks'.